- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02086396
Effect of Weight Loss Diet and Pumpkin Seed Flour Consumption on Obese Women
March 12, 2014 updated by: Anna Paula Soares de Oliveira Carvalho, Universidade Federal do Rio de Janeiro
Effect of Hypoenergetic Diet Combined With Pumpkin Seed Flour Consumption on Obese Women
This study aimed to evaluate the effect of weight loss diet combined with pumpkin seed flour consumption on diet improvement, weight loss, and glucose and cholesterol reduction in obese.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
139
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rio de Janeiro, Brazil, 21941-913
- Federal University of Rio de Janeiro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 59 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age from 20 to 59 years old.
- body mass index above 30 kg/m2
Exclusion Criteria:
- diabetic
- loss weight before the research
- consumption of vitamins or dietary supplement.
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: pumpkin seed flour
The pumpkin seed flour group received 20g/day of pumpkin seed flour during 12 weeks
|
The pumpkin seed flour group received 20g/day of pumpkin seed flour during 12 weeks
|
Placebo Comparator: Cassava flavored flour
The placebo group (cassava flour flavored) received 20g/day of cassava flour flavored during 12 weeks.
|
The group placebo (cassava flour flavored) received 20g/day of cassava flour flavored during 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anthropometric measures
Time Frame: Change from Baseline at 12 weeks
|
body weight (kg), body mass index (kg/m2), waist circumference (cm), neck circumference
|
Change from Baseline at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood lipids
Time Frame: Change from baseline at 12 weeks
|
total Cholesterol (mg/dl), LDL-cholesterol (mg/dl), HDL-cholesterol (mg/dl) and triglycerides (mg/dl)
|
Change from baseline at 12 weeks
|
Blood glucose
Time Frame: Change from baseline at 12 weeks
|
glucose (mg/dL)
|
Change from baseline at 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Glorimar Rosa, Doctor, Universidade Federal do Rio de Janeiro
- Study Chair: Gláucia MM Oliveira, Doctor, Universidade Federal do Rio de Janeiro
- Principal Investigator: Anna SO Carvalho, Master, Universidade Federal do Rio de Janeiro
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Actual)
January 1, 2012
Study Completion (Actual)
September 1, 2013
Study Registration Dates
First Submitted
March 11, 2014
First Submitted That Met QC Criteria
March 12, 2014
First Posted (Estimate)
March 13, 2014
Study Record Updates
Last Update Posted (Estimate)
March 13, 2014
Last Update Submitted That Met QC Criteria
March 12, 2014
Last Verified
March 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACarvalho
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on pumpkin seed flour
-
Texas Woman's UniversityCompletedHypertension | DyslipidemiaUnited States
-
Greenyn Biotechnology Co., Ltd.Taipei Medical UniversityRecruitingDiabetes | Metabolic DiseaseTaiwan
-
Marymount UniversityCompletedHypertension | Elevated Blood PressureUnited States
-
Greenyn Biotechnology Co., Ltd.Taipei Medical University WanFang HospitalRecruiting
-
Texas Woman's UniversityCompleted
-
University of the AegeanActive, not recruiting
-
Ain Shams UniversityNot yet recruitingHemodialysis Patients
-
Ghada zakiNot yet recruiting
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...UnknownKeratotic Nodular SizeBangladesh
-
Mayo ClinicWhole Vine ProductsCompleted1. Endothelial Dysfunction (EndoPAT Score <=2)United States